These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
932 related articles for article (PubMed ID: 36069342)
1. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cheng K; Cai N; Zhu J; Yang X; Liang H; Zhang W Cancer Commun (Lond); 2022 Nov; 42(11):1112-1140. PubMed ID: 36069342 [TBL] [Abstract][Full Text] [Related]
2. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA. Wang C; Chen C; Hu W; Tao L; Chen J Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206 [TBL] [Abstract][Full Text] [Related]
3. Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy. Zhang Y; Han G; Gu J; Chen Z; Wu J Front Immunol; 2024; 15():1429812. PubMed ID: 39170620 [TBL] [Abstract][Full Text] [Related]
4. Macrophages as Targets in Hepatocellular Carcinoma Therapy. Liu YT; Mao ZW; Ding Y; Wang WL Mol Cancer Ther; 2024 Jun; 23(6):780-790. PubMed ID: 38310642 [TBL] [Abstract][Full Text] [Related]
5. Targeting tumor associated macrophages in hepatocellular carcinoma. Xu W; Cheng Y; Guo Y; Yao W; Qian H Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152 [TBL] [Abstract][Full Text] [Related]
6. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review). Yu M; Yu H; Wang H; Xu X; Sun Z; Chen W; Yu M; Liu C; Jiang M; Zhang X Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239752 [TBL] [Abstract][Full Text] [Related]
7. Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma. Sung PS Clin Mol Hepatol; 2022 Jul; 28(3):333-350. PubMed ID: 34665953 [TBL] [Abstract][Full Text] [Related]
8. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway. Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma. Zhang Q; Tsui YM; Zhang VX; Lu AJ; Lee JM; Lee E; Cheung GC; Li PM; Cheung ET; Chia NH; Lo IL; Chan AC; Cheung TT; Ng IO; Ho DW Theranostics; 2024; 14(2):892-910. PubMed ID: 38169544 [No Abstract] [Full Text] [Related]
10. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma. Degroote H; Van Dierendonck A; Geerts A; Van Vlierberghe H; Devisscher L J Immunol Res; 2018; 2018():7819520. PubMed ID: 30410942 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy. Helal IM; Kamal MA; Abd El-Aziz MK; El Tayebi HM Expert Rev Mol Med; 2024 Sep; 26():e18. PubMed ID: 39320855 [TBL] [Abstract][Full Text] [Related]
12. Long F; Zhong W; Zhao F; Xu Y; Hu X; Jia G; Huang L; Yi K; Wang N; Si H; Wang J; Wang B; Rong Y; Yuan Y; Yuan C; Wang F Theranostics; 2024; 14(12):4822-4843. PubMed ID: 39239526 [No Abstract] [Full Text] [Related]
13. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648 [TBL] [Abstract][Full Text] [Related]
14. Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma. Li D; Zhang T; Guo Y; Bi C; Liu M; Wang G Cell Death Dis; 2024 Jul; 15(7):498. PubMed ID: 38997297 [TBL] [Abstract][Full Text] [Related]
15. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. Jiang Y; Han Q; Zhao H; Zhang J J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720 [TBL] [Abstract][Full Text] [Related]
16. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy. Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417 [TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells. Polidoro MA; Mikulak J; Cazzetta V; Lleo A; Mavilio D; Torzilli G; Donadon M World J Gastroenterol; 2020 Sep; 26(33):4900-4918. PubMed ID: 32952338 [TBL] [Abstract][Full Text] [Related]
19. M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma. Sun D; Luo T; Dong P; Zhang N; Chen J; Zhang S; Dong L; Janssen HLA; Zhang S J Cell Biochem; 2020 Apr; 121(4):2828-2838. PubMed ID: 31692069 [TBL] [Abstract][Full Text] [Related]
20. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression. Zhang Q; Lou Y; Bai XL; Liang TB World J Gastroenterol; 2018 Aug; 24(31):3500-3512. PubMed ID: 30131656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]